The Vascular Biology Program

Ischemic cardiovascular disease—conditions of reduced bloodflow to the heart—is the most common cause of death in the developed world. Countless lives could be saved if it were possible to coax new blood vessels to grow to treat such conditions. Researchers in our Vascular Biology program at ICE focus on angiogenesis and vascular biology with the ultimate goal of developing new clinical treatments. One specific focus is the use of bone marrow-derived vascular progenitor cells for the treatment of ischemic cardiovascular disease.

Faculty

Jeff W.M. Bulte, Ph.D.
Assaf A. Gilad, Ph.D.
Andre Levchenko, M.D.
Gregg Semenza, M.D., Ph.D., Director
Piotr Walczak, M.D., Ph.D.